Eifelhoehen-Klinik AG
F:EIF
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1.1
2.1
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Eifelhoehen-Klinik AG
Eifelhoehen-Klinik AG
Capital Expenditures
Eifelhoehen-Klinik AG
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Eifelhoehen-Klinik AG
F:EIF
|
Capital Expenditures
-€488k
|
CAGR 3-Years
-57%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
Rhoen Klinikum AG
XETRA:RHK
|
Capital Expenditures
-€73.1m
|
CAGR 3-Years
8%
|
CAGR 5-Years
14%
|
CAGR 10-Years
6%
|
|
|
M1 Kliniken AG
XETRA:M12
|
Capital Expenditures
-€1.2m
|
CAGR 3-Years
10%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Mediclin AG
XETRA:MED
|
Capital Expenditures
-€42.9m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-9%
|
|
|
MATERNUS-Kliniken-AG
XETRA:MAK
|
Capital Expenditures
-€5.5m
|
CAGR 3-Years
-78%
|
CAGR 5-Years
-47%
|
CAGR 10-Years
-14%
|
|
|
M
|
MedNation AG
SWB:EIF
|
Capital Expenditures
-€488k
|
CAGR 3-Years
-57%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
Eifelhoehen-Klinik AG
Glance View
Eifelhöhen-Klinik AG operates facilities for the provision of inpatient and outpatient rehabilitation, elderly care, and outpatient medical care. The company is headquartered in Bonn, Nordrhein-Westfalen and currently employs 390 full-time employees. The company operates the Eifelhoehen-Klinik Marmagen GmbH in Nettersheim-Marmagen, a specialist clinic for outpatient and inpatient internal medicine, orthopedics/traumatology, neurology; the Kaiser-Karl-Klinik GmbH in Bonn, a specialist clinic for outpatient and inpatient orthopedics, geriatrics and internal medicine, as well as the Herzpark Moenchengladbach GmbH in Moenchengladbach, a specialist clinic for outpatient and inpatient cardiac rehabilitation. In addition to that it owns a majority stake in Aatalklinik Wuennenberg GmbH and a minority stake in geriatric center Zuelpich GmbH.
See Also
What is Eifelhoehen-Klinik AG's Capital Expenditures?
Capital Expenditures
-488k
EUR
Based on the financial report for Jun 30, 2024, Eifelhoehen-Klinik AG's Capital Expenditures amounts to -488k EUR.
What is Eifelhoehen-Klinik AG's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
4%
Over the last year, the Capital Expenditures growth was -18%. The average annual Capital Expenditures growth rates for Eifelhoehen-Klinik AG have been -57% over the past three years , 4% over the past five years .
You don't have any saved screeners yet
